# NSF Awards Informuta Clinical Validation Grant

Informuta, a New Orleans-based predictive infection intelligence company, has been awarded a **$1.25 million** National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant to advance its antibiotic resistance forecasting platform toward clinical deployment. This funding supports prospective clinical validation, integration into hospital workflows, and expansion of predictive models, marking a critical step toward commercial readiness and broader adoption in healthcare settings.

- The grant enables Informuta to pursue CLIA certification and CAP accreditation, essential for clinical laboratory operations and regulatory compliance.
- Procurement professionals should note the growing emphasis on AI-driven healthcare technologies and predictive microbiology tools in federal funding programs.
- Contractors specializing in clinical microbiology, laboratory infrastructure, and healthcare AI may find emerging opportunities supporting platform integration and validation efforts.
- This award highlights NSF's role in fostering innovation at the intersection of biotechnology and digital health, signaling potential future procurements in this domain.

**Jurisdictions:** federal
**Industries:** Healthcare, Information Technology
**Topics:** Artificial Intelligence, Regulatory Compliance
**Published:** September 24, 2026

### Government Entities
- National Science Foundation (NSF)
- University of Pittsburgh Medical Centre
- University of California, Irvine

### Vendors
- Informuta (awardee)

### Key Quotes
> Informuta won the BioChallenge, built its lab here at NOBIC and is now taking important steps toward CLIA certification and CAP accreditation 	6 all milestones that move the company closer to commercial readiness.
> — Kris Khalil, Executive Director of NOBIC

### Sources
- [Informuta awarded NSF SBIR Phase II grant - Scientist Live](https://www.scientistlive.com/informuta-awarded-nsf-sbir-phase-ii-grant) - scientistlive.com